uniQure (QURE) Retained Earnings (2015 - 2026)
uniQure (QURE) posted quarterly Retained Earnings of $1.8 billion for Q2 2026, up 45.83% year-over-year from $1.3 billion in Q2 2025, and up 15.98% quarter-over-quarter from $1.6 billion in Q1 2026.
uniQure (QURE) Retained Earnings (2015 - 2026) Analysis & Trends
uniQure's Retained Earnings history runs 12 years deep, the most recent figure standing at $1.8 billion for Q2 2026.
- In Q2 2026, Retained Earnings rose 45.83% year-over-year to $1.8 billion; the TTM figure through Jun 2026 stood at $1.8 billion (up 45.83% YoY), while the FY2025 annual figure was $1.6 billion, up 34.89% from the prior year.
- Retained Earnings for Q2 2026 stood at $1.8 billion, up from $1.6 billion in the prior quarter.
- The five-year high for Retained Earnings was $1.8 billion in Q2 2026, with the low at -$58.3 million in Q4 2022.
- The 5-year median for Retained Earnings is $1.2 billion (2024), against an average of $1.2 billion.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings sank 101.73% in 2022, then soared 2070.41% in 2023.
- uniQure's Retained Earnings stood at -$58.3 million in 2022, then jumped by 2070.41% to $1.1 billion in 2023, then grew by 2.12% to $1.2 billion in 2024, then jumped by 34.89% to $1.6 billion in 2025, then increased by 16.39% to $1.8 billion in 2026.
- Business Quant data shows QURE's Retained Earnings at $1.8 billion in Q2 2026, $1.6 billion in Q1 2026, and $1.6 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | 1.84 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.84 Bn |
| Mar 31, 2026 | 1.59 Bn |
| Dec 31, 2025 | 1.58 Bn |
| Sep 30, 2025 | 1.58 Bn |
| Jun 30, 2025 | 1.26 Bn |
| Mar 31, 2025 | 1.26 Bn |
| Dec 31, 2024 | 1.17 Bn |
| Sep 30, 2024 | 1.17 Bn |
| Jun 30, 2024 | 1.16 Bn |
| Mar 31, 2024 | 1.16 Bn |
| Dec 31, 2023 | 1.15 Bn |
| Sep 30, 2023 | 1.14 Bn |
| Jun 30, 2023 | 1.13 Bn |
| Mar 31, 2023 | 1.12 Bn |
| Dec 31, 2022 | -58.30 Mn |
| Sep 30, 2022 | 1.10 Bn |
| Jun 30, 2022 | 1.09 Bn |
| Mar 31, 2022 | 1.08 Bn |
| Dec 31, 2021 | -28.90 Mn |
| Sep 30, 2021 | 1.07 Bn |